Siemens India Provides Critical Diagnostics Equipment for COVID-19 Response to Government Medical College and Hospital, Aurangabad

    0
    120

    AURANGABAD, MH, India, Apr 21, 2021 – Siemens Limited provided critical diagnostics equipment for COVID-19 response to Government Medical College and Hospital, Aurangabad.

    The equipment includes a fully-automated RNA extractor instrument, 1,00,000 units of ICMR-approved magnetic bead-based Nucleic acid extraction (COVID-19 RNA) and 2 real-time PCR (polymerase chain reaction) analyzer instruments with data station.

    “We would like to support the local authorities in Aurangabad in the fight against COVID-19. The equipment will further strengthen the capacity of Aurangabad in its response to COVID-19 and help save lives,” said Sunil Mathur, Managing Director and Chief Executive Officer, Siemens Limited.

    About Siemens Limited 

    Siemens Limited focuses on intelligent infrastructure for buildings and distributed energy systems and on automation and digitalization in the process, discrete & hybrid manufacturing industries. The Company brings together the digital and physical worlds to benefit customers and society. It offers broad expertise across the entire energy value chain, along with a comprehensive portfolio for utilities, independent power producers, transmission system operators, the oil and gas industry, and other energy-intensive industries. With its products, solutions, systems, and services, it addresses the needs of energy transition, including storage and sector-coupling solutions. It is also a supplier and service provider of intelligent mobility solutions for rail, road and inter-modal transport for passenger and freight services. Siemens Limited is the flagship listed company of Siemens AG in India. As of September 30, 2020, Siemens Limited had Revenue from continuing operations of INR 9,581 crore and 9,258 employees. Further information is available on the Internet at www.siemens.co.in.